Core Competencies
Comprehensive product portfolio
- Over 40 existing formulations which include cytotoxics and cytostatics, both in injectables as well as oral forms.
- Developing cost effective products and innovative formulations.
Cost competitiveness
- End-to-End solution provider, fully integrated from start to finish, certified facilities rolling out state-of-the-art third generation chemotherapeutics and have been approved by authorities such as TGA, USFDA & MHRA.
Speed to market
- Highly experienced regulatory team ensuring pre patent expiry registrations.
- Developing key products by non-infringing processes.
- Experience from less regulated markets provides the opportunity to identify unmet medical/regulatory needs thereby improving these areas when launching into regulated markets.
Research & Development
- Non-infringing methods of developing, manufacturing and formulating active ingredients that are under patent protection.
- Dedicated team of 160 scientists to enable speedy product development.
Strong network
- With operations in every continent, Fresenius Kabi Oncology Limited has one of the best distribution networks in oncology generic.
|
